Stockreport

FDA approves $3.5 million treatment for hemophilia, now the most expensive drug in the world [CNN]

GoodRx Holdings, Inc. - Class A  (GDRX) 
PDF Hemgenix is a gene therapy to treat adults with hemophilia B, a genetic bleeding disorder in which people do not produce a protein needed to create blood clots. About 1 [Read more]